decentralised clinical trials

Cambridge Cognition announces scientific advisory board

/ News

Cambridge, UK – 21 March 2024: Cambridge Cognition, a leader in digital health solutions for brain health assessment, announces the formation of a Scientific Advisory Board (SAB). This expert board will provide scientific guidance and valuable market insights, primarily focusing on addressing emerging trends such as the integration of blood-based biomarkers and the collaborative possibilities […]

Cambridge Cognition announces scientific advisory board Read More »

Technology for successful decentralised clinical trials

/ Insights

The landscape of clinical trials is undergoing a profound transformation, one that holds the promise of faster drug development, increased patient participation, and improved data quality.  At the forefront of this revolution stands the concept of Decentralised Clinical Trials (DCTs), a game-changing approach that is reshaping the way we conduct clinical research. In this blog

Technology for successful decentralised clinical trials Read More »

Cambridge Cognition
Scroll to Top